This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
News & Press: Journals

JTH Releases SSC Guidance: Occult Cancer Screening in Patients with VTE

Monday, August 14, 2017   (0 Comments)
Posted by: Luke Blount
Share |

The Journal of Thrombosis and Haemostasis (JTH) has accepted the following articles on recommendations from the Scientific and Standardization Committee (SSC) of the ISTH:

Subcommittee on Hemostasis and Malignancy
Occult cancer screening in patients with venous thromboembolism
Venous thromboembolism (VTE) can be the first manifestation of cancer. Although four prospective studies have suggested that limited occult cancer screening might be adequate after a first unprovoked VTE [1-4], there is no evidence that it should be applied to all VTE patients (e.g. provoked events; unusual site VTE, etc.). Furthermore, other uncertainties, such as which tests should be performed or whether occult cancer screening should be done after a recurrent VTE event, are still remaining. Read more.

Membership Management Software Powered by YourMembership  ::  Legal